Skip to main content
Interview with the Innovators

Overview of Current Imaging Modalities in Prostate Cancer

Videos
Neal Shore, MD, FACS
Carolina Urologic Research Center
Myrtle Beach, SC
Dr Neal Shore introduces the current global landscape of various imaging modalities for prostate cancer, including a new prostate-specific membrane antigen (PSMA)-targeted PET/CT agent, PYLARIFY® (piflufolastat F 18).

Related Items